Evaluating the Expert Patients Programme - process of implementation and outcomes
| ISRCTN | ISRCTN70532349 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN70532349 |
| Protocol serial number | N/A |
| Sponsor | UK Department of Health |
| Funder | UK Department of Health |
- Submission date
- 28/09/2004
- Registration date
- 12/01/2005
- Last edited
- 24/08/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Anne Rogers
Scientific
Scientific
National Primary Care Research & Development Centre (NPCRDC)
5th Floor, Williamson Building
The University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom
| Phone | +44 (0)161 275 7601 |
|---|---|
| anne.rogers@man.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Evaluating the Expert Patients Programme - process of implementation and outcomes |
| Study acronym | REPORT - Research into Expert Patients Outcomes in a Randomised Trial |
| Study objectives | The RCT is designed to test the clinical and cost-effectiveness of the EPP in the management of chronic conditions in England. A two-arm, patient level, randomised controlled trial: The intervention is the Expert Patient Programme, group-based chronic disease management programme, and the comparator is a 6-month waiting list control group. Patient population is adults with chronic disease, to be recruited from all 27 EPP Zones in the UK. Outcomes: include self-efficacy, health status, quality of life, and health service utilisation |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Chronic condition as defined by the patient |
| Intervention | Randomisation at patient level to either Group 1 who will participate in the Expert Patients Programme (EPP) immediately or Group 2 the waiting list controls who will participate in the EPP six months after recruitment |
| Intervention type | Other |
| Primary outcome measure(s) |
Self-efficacy, health status, quality of life, and health service utilisation |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 28/02/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 600 |
| Key inclusion criteria | All individuals who are referred or self-refer to the Expert Patients Programme |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/04/2003 |
| Date of final enrolment | 28/02/2006 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
National Primary Care Research & Development Centre (NPCRDC)
Manchester
M13 9PL
United Kingdom
M13 9PL
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/03/2007 | Yes | No | |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
